diltiazem has been researched along with cyclosporine in 113 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 62 (54.87) | 18.2507 |
2000's | 31 (27.43) | 29.6817 |
2010's | 17 (15.04) | 24.3611 |
2020's | 3 (2.65) | 2.80 |
Authors | Studies |
---|---|
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
Globisch, C; Kassack, MU; Klinkhammer, W; Müller, H; Pajeva, IK; Wiese, M | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Müller, H; Pick, A; Wiese, M | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Globisch, C; Klinkhammer, W; Müller, H; Pajeva, IK; Wiese, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bauer, S; Brockmöller, J; Kewitz, H; Roots, I | 1 |
Kunzendorf, U; Neumayer, HH; Schreiber, M | 2 |
Connell, J; Harvison, A; Keogh, A; Macdonald, P; Richens, D; Spratt, P | 1 |
Freeman, D; Keown, P; McDonald, J; Petric, R; Stiller, C; Wallace, C | 1 |
Bergström, C; Fellström, B; Frödin, L; Hanås, E; Skarp-Orberg, I; Wahlberg, J | 1 |
Alcaraz, A; Andreu, J; Campistol, JM; Fernandez-Cruz, L; Mañalich, M; Oppenheimer, F; Ricart, MJ; Talbot-Wright, R; Vilardell, J | 1 |
Hunt, CM; Stave, GM; Westerkam, WR | 1 |
Carrier, M; Pelletier, LC; Stewart, D; Tronc, F | 1 |
Hartz, PA; Wilson, PD | 1 |
Solem, LE; Wallace, KB | 1 |
Baysal, K; Brierley, GP; Jung, DW | 1 |
Reams, GP | 1 |
Belitsky, P; Knox, MG; Methot, ME; Nicol, D; Sketris, IS | 1 |
Adamczyk, M; Auch-Schwelk, W; Bossaller, C; Brodde, OE; Busch, F; Duske, E; Fleck, E; Götze, S | 1 |
Gough, J; Jeffery, JR; Rush, DN | 1 |
Carozzi, S; Fontana, I; Nasini, MG; Nocera, A; Pietrucci, A; Valente, U | 1 |
Baraldo, M; Furlanut, M; Puricelli, C | 1 |
Jacobs, U; Klehr, HU; Klein, B | 1 |
Cooke, CE | 1 |
Kudoh, S; Satoh, A | 1 |
Auch-Schwelk, W; Bossaller, C; Fleck, E; Götze, S; Thelen, J | 2 |
Becker, GJ; Choy, BY; Walker, RG | 1 |
Dhawan, I; Masri, MA; Pingle, A; Shakuntala, V; Shanwaz, M; Yasin, I; Zaher, M | 1 |
Brunson, ME; Howard, RJ; Karlix, JL; Patton, PR; Peterson, JC; Pfaff, WW; Ramos, EL | 1 |
Chen, H; Daloze, P; Dumont, L; Garceau, D; Xu, D | 1 |
Cardella, CJ; Leenen, FH; Legault, L; Ogilvie, RI | 1 |
Carrier, M; Nattel, S; Pelletier, LC; Stewart, D; Tronc, F | 1 |
Chrysostomou, A; d'Apice, AJ; Kincaid-Smith, P; Mathew, TH; Russ, GR; Walker, RG | 1 |
Francis, DM; Fullinfaw, R; Higgins, TJ; King, GN; Walker, RG; Wiesenfeld, D | 1 |
Bourge, R; Brozena, SC; Clemson, B; Hobbs, R; Johnson, MR; Miller, L; Mills, RM; Naftel, D; Olivari, MT; Quigg, R; Ventura, H | 1 |
Bader, A; Bleck, JS; Christians, U; Kliem, V; Lampen, A; Manns, M; Repp, H; Sewing, KF; Thiesemann, C; Westhoff-Bleck, M | 1 |
Bleck, JS; Christians, U; Frei, U; Hecker, H; Kliem, V; Manns, M; Repp, H; Sewing, KF; Thiesemann, C; Westhoff-Bleck, M | 1 |
Aydin, AE; Aygün, S; Carin, M; Cebeci, I; Firatli, E; Güç, U; Kantarci, A; Tanyeri, H; Tuncer, O | 1 |
Jones, TE; Morris, RG | 2 |
Jones, TE | 2 |
Keiser, HR; Oriji, GK | 1 |
Jones, TE; Mathew, TH; Morris, RG | 2 |
al Edreesi, M; Caillé, G; Dupuis, C; Paradis, K; Théoret, Y | 1 |
Andersen, RC; Dahl, DC; Goerdt, PJ; Heim-Duthoy, KL; Jacobs, DM; Johnson, HJ; Kasiske, BL; Ney, AL; Odland, MD; Rao, VK | 1 |
Saris, NE | 1 |
D'Ambrosio, A; Quintieri, F; Segoloni, G | 1 |
Christians, U; Korn, A; Sperschneider, H; Wagner, C | 1 |
Figueira, ER; Leitão, RM; Massarollo, PC; Mies, S; Raia, S | 1 |
McLachlan, AJ; Tett, SE | 1 |
Ardiles, L; Elberg, A; Flores, C; Foradori, A; Mezzano, S | 1 |
Elberg, A; Foradori, A; Mezzano, S; Pefaur, J; Videla, C | 1 |
Eichinger, H; Lehle, K; Preuner, JG; Rupprecht, L | 1 |
Balogh, A; Fleck, C; Kostka, E; Kühl, A; Kuhn, UD; Lupp, A; Stein, G | 1 |
Asberg, A; Berg, KJ; Christensen, H; Hartmann, A | 1 |
Cartier, R; Demers, P; Elkouri, S; Mathieu, P | 1 |
Chan, L; Jacob, LP; Malhotra, D; Shapiro, JI | 1 |
Chen, H; Daloze, P; Dumont, L; Lapointe, N; Qi, S; Xu, D | 1 |
Asberg, A; Berg, KJ; Carlson, E; Christensen, H; Schram, L | 1 |
Huang, W; Jiang, TT; Patel, D | 1 |
Asberg, A; Berg, KJ; Carlson, E; Christensen, H; Hartmann, A; Molden, E | 1 |
Oriji, GK | 1 |
Carrier, M; Daly, P; Davies, R; Gudas, V; Kostuk, W; Latter, D; Rivard, M; Sullivan, J; Teo, K; White, M | 1 |
Amano, A; Daikoku, H; Fujimori, Y; Fukui, N; Morisaki, I; Murakami, J | 1 |
Landwojtowicz, E; Seelig, A | 1 |
Akhlaghi, F; Kaan, A; Keogh, AM; McLachlan, AJ | 1 |
Chen, HC; Chen, YL; Cheng, CH; Hsieh, CL; Shu, KH | 1 |
McDonald, SP; Russ, GR | 1 |
Dietl, KH | 1 |
Cook, S; Cooke, R; Fullinfaw, RO; Ilett, KF; Morris, RG; Ray, JE; Tett, SE | 1 |
Fox, DA; Harris, JB; He, L; Medrano, CJ; Poblenz, AT | 1 |
Cea-Calvo, L; de la Calzada, CS; de la Cámara, AG; Delgado, JF; Escribano, P; Gómez-Sánchez, MA; Pascual, JG; Rufilanchas, JJ; Sánchez, V; Sotelo, T | 1 |
Akhlaghi, F; Keogh, AM; McLachlan, AJ; Ray, JE | 1 |
Chan, TM; Haycox, A; Kou, M; Kumana, CR; Lauder, IJ; Lee, JS; Li, CS; Tong, MK; Walley, T | 1 |
Cheranov, SY; Jaggar, JH | 1 |
Alruiz, PA; Ardiles, LG; Aros, CA; Flores, CA; Jerez, V; Mezzano, SA; Schneider, HO | 1 |
Alruiz, PA; Ardiles, LG; Aros, CA; Flores, CA; Jerez, VR; Mezzano, SA; Schneider, HO | 1 |
Asahi, S; Katoh, M; Suzuyama, N; Takeuchi, T; Yokoi, T; Yoshitomi, S | 1 |
Bunnag, S; Ong-ajyooth, L; Vareesangthip, K | 1 |
Chalermsanyakorn, P; Ingsathit, A; Jirasiritham, S; Sumethkul, V | 1 |
Keogh, AM; McLachlan, AJ; Ray, JE | 1 |
Inamdar, MN; Kumar, NP; Venkataraman, BV | 1 |
Chen, LQ; Chen, LZ; Chen, YH; Hu, JB; Li, WL; Liang, JJ; Liang, YX; Qiu, J; Xie, KJ; Zhang, J; Zheng, KL; Zhong, WD | 1 |
Bi, H; Chen, X; Huang, M; Li, J; Wang, C; Wang, X; Wang, Y; Zhu, G | 1 |
Colucci, M; D'Ambrosio, A; Giordani, L; Quintieri, F; Vanacore, N | 1 |
Dönmez, O; Durmaz, O | 1 |
Ding, X; Feng, X; Hou, J; Pan, X; Tian, P; Tian, X; Xiang, H; Xue, W; Yan, H | 1 |
Ding, X; Fan, X; Feng, X; Hou, J; Pan, X; Qin, G; Song, Y; Tian, P; Tian, X; Xiang, H; Xue, W; Yan, H | 1 |
Atteno, M; Cantarini, L; Caso, F; Costa, L; Cozzi, F; Punzi, L; Scarpa, R; Sfriso, P | 1 |
Huang, M; Li, JL; Wang, CX; Wang, XD; Wang, YX; Zhang, Y | 1 |
Shalaby, U | 1 |
Chen, L; Chen, Y; Lei, W; Li, M; Liang, J; Lin, Y; Lu, Y; Yang, J; Zhang, J; Zhang, Z | 1 |
Kurniawan, MZ; Lusida, M; Nugroho, J | 1 |
Bacon, S; Croker, R; Curtis, HJ; Goldacre, B; MacKenna, B; Walker, AJ | 1 |
Alyaydin, E; Reinecke, H; Sindermann, JR; Tuleta, I | 1 |
3 review(s) available for diltiazem and cyclosporine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Do calcium channel blockers have renal protective effects?
Topics: Aging; Animals; Calcium Channel Blockers; Clinical Trials as Topic; Cyclosporine; Diabetic Nephropathies; Dihydropyridines; Diltiazem; Disease Models, Animal; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension, Renal; Kidney; Kidney Transplantation; Rats; Rats, Inbred SHR; Verapamil | 1994 |
The use of other drugs to allow a lower dosage of cyclosporin to be used. Therapeutic and pharmacoeconomic considerations.
Topics: Aryl Hydrocarbon Hydroxylases; Australia; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Diltiazem; Drug Synergism; Enzyme Inhibitors; Graft Rejection; Humans; Immunosuppressive Agents; Ketoconazole; New Zealand; Organ Transplantation; Oxidoreductases, N-Demethylating | 1997 |
25 trial(s) available for diltiazem and cyclosporine
Article | Year |
---|---|
Protective effects of calcium antagonists in human renal transplantation.
Topics: Acute Kidney Injury; Adult; Creatinine; Cyclosporine; Diltiazem; Graft Rejection; Humans; Iloprost; Kidney Transplantation; Middle Aged; Prospective Studies | 1992 |
Protective effects of diltiazem and the prostazycline analogue iloprost in human renal transplantation.
Topics: Acute Kidney Injury; Adult; Cyclosporine; Diltiazem; Follow-Up Studies; Graft Survival; Humans; Iloprost; Immunosuppression Therapy; Kidney Transplantation; Middle Aged; Organ Preservation; Prospective Studies | 1992 |
Diltiazem co-administration reduces cyclosporine toxicity after heart transplantation: a prospective randomised study.
Topics: Actuarial Analysis; Adult; Cyclosporine; Diltiazem; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Male; Prospective Studies; Survival Analysis; Time Factors | 1992 |
Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients.
Topics: Azathioprine; Creatinine; Cyclosporine; Diltiazem; Drug Administration Schedule; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Function Tests; Kidney Transplantation; Prednisolone; Prospective Studies | 1992 |
Influence of the calcium blocker diltiazem on the prevention of acute renal failure after renal transplantation.
Topics: Adult; Cyclosporine; Diltiazem; Female; Follow-Up Studies; Graft Rejection; Humans; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Male; Probability; Time Factors | 1992 |
Sequential protocol biopsies in renal transplant patients: repeated inflammation is associated with impaired graft function at 1 year.
Topics: Adult; Biopsy, Needle; Cyclosporine; Diltiazem; Follow-Up Studies; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Predictive Value of Tests; Time Factors | 1995 |
Immunosuppressive effects of different calcium channel blockers in human kidney allografts.
Topics: Calcium; Calcium Channel Blockers; Cyclosporine; Cytokines; Diltiazem; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Isradipine; Kidney Transplantation; Lymphocytes; Prednisolone; Transplantation, Homologous; Verapamil | 1995 |
A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome.
Topics: Adult; Blood Pressure; Costs and Cost Analysis; Creatinine; Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Female; Graft Rejection; Humans; Ketoconazole; Kidney; Kidney Transplantation; Male; Middle Aged; Treatment Outcome | 1994 |
Calcium antagonists in heart transplant recipients: effects on cardiac and renal function and cyclosporine pharmacokinetics.
Topics: Cyclosporine; Diltiazem; Heart Transplantation; Hemodynamics; Humans; Hypertension; Immunosuppression Therapy; Kidney; Kidney Function Tests; Male; Middle Aged; Nifedipine | 1993 |
Diltiazem in renal allograft recipients receiving cyclosporine.
Topics: Adult; Blood Pressure; Cyclosporine; Diltiazem; Drug Therapy, Combination; Female; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Transplantation, Homologous | 1993 |
Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. Results of a prospective, randomized multicenter trail.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cyclosporine; Diltiazem; Female; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Lisinopril; Male; Middle Aged; Postoperative Complications; Prospective Studies; Treatment Outcome | 1996 |
Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients.
Topics: Adult; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Cyclosporine; Diltiazem; Female; Half-Life; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Sex Factors | 1996 |
Formulation of diltiazem affects cyclosporin-sparing activity.
Topics: Adult; Antihypertensive Agents; Child; Cyclosporine; Delayed-Action Preparations; Diffusion; Diltiazem; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged | 1997 |
Safety, tolerability, and pharmacokinetic actions of diltiazem in pediatric liver transplant recipients on cyclosporine.
Topics: Adolescent; Calcium Channel Blockers; Child; Child, Preschool; Creatinine; Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Liver; Liver Transplantation; Male; Prospective Studies; Safety; Treatment Outcome | 1995 |
A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients.
Topics: Adult; Antilymphocyte Serum; Cadaver; Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Therapy, Combination; Feasibility Studies; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Pilot Projects; Prospective Studies; T-Lymphocytes; Time Factors | 1997 |
[Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients].
Topics: Adult; Biotransformation; Calcium Channel Blockers; Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Metabolic Clearance Rate; Middle Aged; Nifedipine; Prospective Studies; Structure-Activity Relationship | 1997 |
Study of neoral kinetics in adult renal transplantation treated with diltiazem.
Topics: Administration, Oral; Adult; Calcium Channel Blockers; Cyclosporine; Diltiazem; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Metabolic Clearance Rate; Middle Aged; Time Factors | 1998 |
Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazol in stable adult kidney transplants.
Topics: Administration, Oral; Adult; Antifungal Agents; Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Half-Life; Humans; Immunosuppressive Agents; Ketoconazole; Kidney Transplantation; Regression Analysis | 1998 |
A simple and sensitive high-performance liquid chromatography assay of diltiazem and main metabolites in renal transplanted patients.
Topics: Adult; Aged; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Cyclosporine; Diltiazem; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Sensitivity and Specificity | 1999 |
Oral dosing of tacrolimus and cyclosporine microemulsion--results from a large multicenter study in renal transplantation.
Topics: Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Emulsions; Europe; Female; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Survival Analysis; Tacrolimus | 2002 |
Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporin.
Topics: Adolescent; Adult; Aged; Cost Savings; Cyclosporine; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Quality of Life; Transplantation, Homologous; Treatment Outcome | 2003 |
Correlation Between C2 and AUC(0-4) in Renal Transplant Patients Treated With Diltiazem.
Topics: Adult; Aged; Area Under Curve; Cyclosporine; Diltiazem; Drug Monitoring; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Vasodilator Agents | 2005 |
No gender-associated differences of cyclosporine pharmacokinetics in stable renal transplant patients treated with diltiazem.
Topics: Area Under Curve; Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Interactions; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Sex Characteristics | 2005 |
Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China.
Topics: Adolescent; Adult; Aged; Azathioprine; Cohort Studies; Cyclosporine; Diltiazem; Drug Combinations; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Liver Function Tests; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Young Adult | 2011 |
Diltiazem co treatment with cyclosporine for induction of disease remission in sight-threatening non-infectious intraocular inflammation.
Topics: Adult; Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Remission Induction; Uveitis; Vasodilator Agents | 2017 |
85 other study(ies) available for diltiazem and cyclosporine
Article | Year |
---|---|
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
New functional assay of P-glycoprotein activity using Hoechst 33342.
Topics: Adenosine Triphosphatases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fluoresceins; Humans; Microscopy, Fluorescence; Molecular Structure; Principal Component Analysis; Time Factors | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structure-activity relationships of new inhibitors of breast cancer resistance protein (ABCG2).
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Models, Molecular; Molecular Structure; Neoplasm Proteins; Phthalic Acids; Quantitative Structure-Activity Relationship; Quinolines; Reproducibility of Results; Stereoisomerism; Time Factors; Tumor Cells, Cultured | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dogs; Drug Resistance, Multiple; Magnetic Resonance Spectroscopy; Models, Molecular | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effect of the new immunosuppressive drug FK506 on the formation of secondary metabolites of cyclosporin A.
Topics: Biotransformation; Cyclosporine; Diltiazem; Erythromycin; Humans; Immunosuppressive Agents; In Vitro Techniques; Microsomes, Liver; Tacrolimus | 1992 |
Amelioration of experimental cyclosporine nephrotoxicity by calcium channel inhibition.
Topics: Animals; Calcium Channel Blockers; Cyclosporine; Diltiazem; Glomerular Filtration Rate; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Renal Circulation; Thromboxane B2 | 1992 |
Effect of age and gender on the activity of human hepatic CYP3A.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alcohol Drinking; Aryl Hydrocarbon Hydroxylases; Body Weight; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diltiazem; Humans; Lidocaine; Microsomes, Liver; Middle Aged; Nifedipine; Oxidoreductases, N-Demethylating; Quinidine; Sex Factors; Smoking | 1992 |
Dose-dependent effect of cyclosporin on renal arterial resistance in dogs.
Topics: Animals; Blood; Cyclosporine; Diltiazem; Dogs; Dose-Response Relationship, Drug; Endothelins; Kidney; Nitric Oxide; Nitroglycerin; Phentolamine; Receptors, Adrenergic, alpha; Renal Artery; Renal Veins; Sympathectomy; Vascular Resistance | 1991 |
Mechanisms of cyclosporine A toxicity in defined cultures of renal tubule epithelia: a role for cysteine proteases.
Topics: Animals; Calcium; Cell Death; Cells, Cultured; Cyclosporine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Diltiazem; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Humans; Kidney Diseases; Kidney Tubules; Leucine; Microscopy, Fluorescence; Nifedipine; Rabbits; Time Factors; Verapamil | 1991 |
Selective activation of the sodium-independent, cyclosporin A-sensitive calcium pore of cardiac mitochondria by doxorubicin.
Topics: Animals; Calcium; Calcium Channels; Cell Fractionation; Cyclosporine; Diltiazem; Doxorubicin; In Vitro Techniques; Male; Membrane Potentials; Mitochondria, Heart; Rats; Rats, Sprague-Dawley; Ruthenium Red; Sodium | 1993 |
The sodium-calcium antiport of heart mitochondria is not electroneutral.
Topics: Animals; Antiporters; Calcium; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cattle; Cyclosporine; Diltiazem; Fluorescent Dyes; Hydrogen-Ion Concentration; Membrane Potentials; Mitochondria, Heart; Nigericin; Onium Compounds; Organophosphorus Compounds; Oxygen; Sodium; Sodium-Calcium Exchanger; Thermodynamics; Valinomycin | 1995 |
Effect of calcium-channel blockers on cyclosporine clearance and use in renal transplant patients.
Topics: Administration, Oral; Adult; Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Interactions; Female; Graft Survival; Humans; Immunosuppression Therapy; Infusions, Intravenous; Kidney; Kidney Transplantation; Male; Middle Aged; Nifedipine; Nova Scotia; Retrospective Studies; Time Factors; Verapamil | 1994 |
Selective downregulation of rat cardiac beta 1-adrenoceptors by cyclosporine A: prevention by diltiazem or angiotensin-converting enzyme inhibitors.
Topics: Animals; Cyclosporine; Diltiazem; Down-Regulation; Enalapril; Heart; Male; Myocardium; Rats; Rats, Wistar; Receptors, Adrenergic, beta-1 | 1995 |
No effect of clodronate on cyclosporin A blood levels in heart transplant patients simultaneously treated with diltiazem and azathioprine.
Topics: Adult; Aged; Azathioprine; Clodronic Acid; Cyclosporine; Diltiazem; Drug Interactions; Female; Heart Transplantation; Humans; Male; Middle Aged | 1994 |
Cumulative side effects of cyclosporine and Ca antagonists: hypergalactinemia, mastadenoma, and gynecomastia.
Topics: Adenoma; Adult; Aged; Breast Neoplasms, Male; Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Synergism; Female; Galactorrhea; Gynecomastia; Humans; Kidney Transplantation; Male; Middle Aged; Nifedipine; Nitrendipine | 1994 |
Nontherapeutic cyclosporine levels. Sustained-release diltiazem products are not the same.
Topics: Cyclosporine; Delayed-Action Preparations; Diltiazem; Drug Interactions; Humans | 1994 |
[Basic studies on the prevention of cyclosporin A induced nephrotoxicity].
Topics: Animals; Cyclosporine; Diltiazem; Humans; Kidney; Kidney Diseases; Lymphocyte Activation; Male; Rats; Rats, Wistar; Theophylline | 1994 |
Preventive effects of diltiazem on cyclosporin A-induced vascular smooth muscle dysfunction.
Topics: Animals; Blood Pressure; Constriction, Pathologic; Cyclosporine; Diltiazem; Isometric Contraction; Male; Muscle, Smooth, Vascular; Random Allocation; Rats; Rats, Wistar; Vasoconstrictor Agents | 1994 |
Vasculopathy in cyclosporine-treated renal allografts: possible protection by diltiazem.
Topics: Adult; Arterioles; Azathioprine; Cyclosporine; Diltiazem; Female; Humans; Image Processing, Computer-Assisted; Kidney; Kidney Transplantation; Male; Prednisolone; Vascular Diseases | 1994 |
Pharmacokinetics of cyclosporine in renal transplant patients on diltiazem.
Topics: Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Humans; Kidney Transplantation | 1994 |
Calcium entry blockade may prevent cyclosporin A-induced hypersensitivity to angiotensin II and endothelial dysfunction in the rat aorta.
Topics: Angiotensin II; Animals; Aorta; Cyclosporine; Diltiazem; Endothelium, Vascular; Male; Muscle Contraction; Muscle, Smooth, Vascular; Random Allocation; Rats; Rats, Wistar; Vasodilation | 1993 |
Immunosuppressive properties of the benzothiazepine calcium antagonists diltiazem and clentiazem, with and without cyclosporine, in heterotopic rat heart transplantation.
Topics: Animals; Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Rats; Rats, Inbred Lew; Rats, Inbred WF; Time Factors; Transplantation, Heterotopic; Transplantation, Homologous; Transplantation, Isogeneic | 1993 |
Blockade of cyclosporine-induced vasoconstriction by the calcium channel blocker diltiazem in dogs.
Topics: Animals; Cyclosporine; Diltiazem; Dogs; Endothelins; Hindlimb; Nitroprusside; Renal Artery; Renal Circulation; Vasoconstriction | 1993 |
Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists.
Topics: Adult; Cross-Sectional Studies; Cyclosporine; Dental Calculus; Dental Plaque Index; Diltiazem; Drug Interactions; Female; Gingival Hyperplasia; Humans; Hypertension; Kidney Transplantation; Male; Middle Aged; Models, Dental; Nifedipine; Periodontal Index; Saliva | 1993 |
Are cytochrome P450 3A enzymes in the small intestine responsible for different cyclosporine metabolite patterns in stable male and female renal allograft recipients after co-administration of diltiazem?
Topics: Adolescent; Adult; Aged; Calcium Channel Blockers; Cyclosporine; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Diltiazem; Duodenum; Female; Humans; Immunosuppressive Agents; Intestinal Mucosa; Kidney Transplantation; Male; Metabolic Clearance Rate; Microsomes; Middle Aged; Mixed Function Oxygenases; Sex Characteristics | 1996 |
Evaluation of the frequency of HLA determinants in patients with gingival overgrowth induced by cyclosporine-A.
Topics: Adult; Antigenic Variation; Calcium Channel Blockers; Chi-Square Distribution; Cyclosporine; Diltiazem; Disease Susceptibility; Drug Combinations; Female; Gingival Overgrowth; HLA Antigens; HLA-DR1 Antigen; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Nifedipine; Pharmacogenetics; Statistics, Nonparametric; Verapamil | 1996 |
Diltiazem does not always increase blood cyclosporin concentration.
Topics: Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Interactions; Female; Humans; Immunosuppressive Agents; Middle Aged | 1996 |
Survey of cyclosporin-sparing agent use in Australasian transplant centres.
Topics: Australia; Cyclosporine; Diltiazem; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Ketoconazole; New Zealand; Organ Transplantation; Surveys and Questionnaires | 1996 |
Cyclosporine A-induced contractions and prostacyclin release are maintained by extracellular calcium in rat aortic rings: role of protein kinase C.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Aorta; Calcium Channel Blockers; Cell Membrane; Cyclosporine; Cytosol; Diltiazem; Enzyme Inhibitors; Epoprostenol; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Staurosporine; Thapsigargin | 1997 |
On the mechanism of rebounding of calcium in liver mitochondria.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium-Binding Proteins; Cyclosporine; Diltiazem; Intracellular Membranes; Malonates; Membrane Potentials; Mitochondria, Liver; Permeability; Rats; Ruthenium Red; Sodium-Calcium Exchanger | 1997 |
Diltiazem-cyclosporin pharmacokinetic interaction--dose-response relationship.
Topics: Adult; Area Under Curve; Calcium Channel Blockers; Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged | 1997 |
The modulatory effect of diltiazem on human in vitro alloreactivity when used alone or in combination with cyclosporin A and/or methylprednisolone.
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents; Calcium Channel Blockers; Cell Survival; Cells, Cultured; Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Lymphocytes; Methylprednisolone | 1997 |
Lower incidence of liver graft rejection in patients on diltiazem plus cyclosporine therapy.
Topics: Acute Disease; Adolescent; Adult; Aged; Calcium Channel Blockers; Child; Cyclosporine; Diltiazem; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Middle Aged; Muromonab-CD3; Retrospective Studies | 1998 |
Diltiazem disposition and metabolism in recipients of renal transplants.
Topics: Calcium Channel Blockers; Chemistry, Pharmaceutical; Cyclosporine; Delayed-Action Preparations; Diltiazem; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Kidney Transplantation; Tissue Distribution | 1998 |
Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approach.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Calcium Channel Blockers; Child; Cyclosporine; Diltiazem; Drug Administration Schedule; Drug Interactions; Fluconazole; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Individuality; Itraconazole; Ketoconazole; Linear Models; Middle Aged | 1998 |
First-pass metabolism of cyclosporine A in human intestine: inhibition by diltiazem.
Topics: Administration, Oral; Biotransformation; Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Interactions; Half-Life; Heart Transplantation; Humans; Immunosuppressive Agents; Injections, Intravenous; Intestinal Absorption; Intestinal Mucosa; Intestines; Liver; Male; Middle Aged; Patient Selection; Tissue Distribution | 1998 |
Is there a beneficial effect of the calcium channel blocker diltiazem on cyclosporine A nephrotoxicity in rats?
Topics: Animals; Body Weight; Calcium Channel Blockers; Cyclosporine; Cytochrome P-450 Enzyme System; Diltiazem; Drug Interactions; Ethylmorphine; Female; Glomerular Filtration Rate; Glutathione; Immunosuppressive Agents; Kidney; Kidney Diseases; Liver; Organ Size; p-Aminohippuric Acid; Rats; Rats, Wistar | 1998 |
Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cyclosporine; Diltiazem; Endothelin-1; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Renal Circulation; Vasoconstriction | 1998 |
[The vasoconstrictor effect of cyclosporine on the pulmonary vein is mediated by its vehicle: the cremophor].
Topics: Animals; Bicyclic Monoterpenes; Calcium Channel Blockers; Calcium Channels; Cyclooxygenase Inhibitors; Cyclosporine; Diltiazem; Dogs; Immunosuppressive Agents; Indomethacin; Isometric Contraction; Muscle, Smooth, Vascular; Pharmaceutical Vehicles; Polyethylene Glycols; Pulmonary Veins; Thromboxane A2; Vasoconstriction; Vasodilator Agents | 1998 |
Absence of a dose-response of cyclosporine levels to clinically used doses of diltiazem and verapamil.
Topics: Administration, Oral; Calcium Channel Blockers; Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Isradipine; Medical Records; Nifedipine; Radioimmunoassay; Retrospective Studies; Verapamil | 1999 |
Immunomodulating effects of second-generation calcium channel blockers on experimental heart transplantation.
Topics: Adjuvants, Immunologic; Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Therapy, Combination; Felodipine; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Mibefradil; Rats; Rats, Inbred Lew; Tetrahydronaphthalenes; Time Factors | 1999 |
Cyclosporine-induced encephalopathy predisposed by diltiazem in a patient with aplastic anemia.
Topics: Aged; Anemia, Aplastic; Brain Diseases; Calcium Channel Blockers; Cyclosporine; Diltiazem; Female; Humans; Immunosuppressive Agents; Thrombocytopenia | 1999 |
Pharmacokinetic interactions between microemulsion formulated cyclosporine A and diltiazem in renal transplant recipients.
Topics: Adult; Aged; Antihypertensive Agents; Cyclosporine; Diltiazem; Drug Interactions; Emulsions; Enzyme Inhibitors; Female; Humans; Kidney; Kidney Transplantation; Male; Middle Aged | 1999 |
Cyclosporine A-induced prostacyclin release is maintained by extracellular calcium in rat aortic endothelial cells: role of protein kinase C.
Topics: Animals; Aorta; Calcium; Calcium Channel Blockers; Cyclosporine; Diltiazem; Endothelium, Vascular; Epoprostenol; Male; Protein Kinase C; Rats; Thapsigargin | 1999 |
The Canadian Study of Cardiac Transplantation. Atherosclerosis. Investigators of the CASCADE Study.
Topics: Adult; Antihypertensive Agents; Arteriosclerosis; Aspirin; Cardiovascular Agents; Cyclosporine; Cytomegalovirus Infections; Diltiazem; Female; Follow-Up Studies; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Ischemia; Postoperative Care; Postoperative Complications | 1999 |
Effects of combined oral treatments with cyclosporine A and nifedipine or diltiazem on drug-induced gingival overgrowth in rats.
Topics: Administration, Oral; Analysis of Variance; Animals; Body Weight; Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Combinations; Drug Interactions; Gingiva; Gingival Overgrowth; Growth; Immunosuppressive Agents; Male; Nifedipine; Rats; Rats, Inbred F344; Single-Blind Method | 2000 |
Structure-activity relationship of P-glycoprotein substrates and modifiers.
Topics: Adenosine Triphosphatases; Amiodarone; Amitriptyline; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; CHO Cells; Colchicine; Cricetinae; Cyclosporine; Daunorubicin; Diltiazem; Kinetics; Micelles; Progesterone; Propranolol; Structure-Activity Relationship; Verapamil; Vinblastine | 2000 |
Pharmacokinetics of cyclosporine in heart transplant recipients receiving metabolic inhibitors.
Topics: Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Interactions; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Ketoconazole; Linear Models; Male; Middle Aged; Multivariate Analysis | 2001 |
Effect of calcium channel antagonist diltiazem and calcium ionophore A23187 on cyclosporine A-induced apoptosis of renal tubular cells.
Topics: Animals; Apoptosis; Calcimycin; Calcium; Calcium Channel Blockers; Caspase 3; Caspases; Cells, Cultured; Cyclosporine; Diltiazem; DNA Fragmentation; DNA-Binding Proteins; Dogs; Enzyme Activation; Gene Expression; Genes, bcl-2; Ionophores; Kidney Tubules; NFATC Transcription Factors; Nuclear Proteins; Transcription Factors | 2002 |
Associations between use of cyclosporine-sparing agents and outcome in kidney transplant recipients.
Topics: Adjuvants, Immunologic; Cohort Studies; Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Proportional Hazards Models; Registries; Survival Analysis; Time Factors; Treatment Outcome | 2002 |
Cyclosporin monitoring in Australasia: 2002 update of consensus guidelines.
Topics: Area Under Curve; Asia; Australia; Cyclosporine; Diltiazem; Drug Interactions; Drug Monitoring; Drugs, Generic; Guidelines as Topic; Humans; Immunoassay; Indicator Dilution Techniques; Quality Control; Reproducibility of Results | 2002 |
Pharmacological strategies to block rod photoreceptor apoptosis caused by calcium overload: a mechanistic target-site approach to neuroprotection.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Apoptosis; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Caspase 3; Caspases; Cyclosporine; Cytochrome c Group; Cytoprotection; Diltiazem; Female; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Organometallic Compounds; Oxygen Consumption; Rats; Rats, Long-Evans; Retinal Degeneration; Retinal Rod Photoreceptor Cells; Sodium-Calcium Exchanger; Verapamil | 2003 |
Impact of diltiazem administration and cyclosporine levels on the incidence of acute rejection in heart transplant patients.
Topics: Acute Disease; Adolescent; Adult; Antihypertensive Agents; Cyclosporine; Diltiazem; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Time Factors | 2003 |
Cyclosporin C(2) and C(0) concentration monitoring in stable, long-term heart transplant recipients receiving metabolic inhibitors.
Topics: Antifungal Agents; Area Under Curve; Biological Availability; Calcium Channel Blockers; Cyclosporine; Cyclosporins; Diltiazem; Dose-Response Relationship, Drug; Drug Monitoring; Enzyme Inhibitors; Female; Heart Transplantation; Humans; Ketoconazole; Male; Middle Aged; Predictive Value of Tests; Statistics as Topic; Time; Time Factors | 2003 |
Mitochondrial modulation of Ca2+ sparks and transient KCa currents in smooth muscle cells of rat cerebral arteries.
Topics: Animals; Bongkrekic Acid; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Calcium-Binding Proteins; Calcium-Transporting ATPases; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cells, Cultured; Cerebral Arteries; Clonazepam; Cyclosporine; Diltiazem; Female; Hydrogen Peroxide; Indazoles; Ion Channels; Male; Membrane Potentials; Microscopy, Confocal; Mitochondria, Muscle; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocytes, Smooth Muscle; Oligomycins; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Rhodamines; Rotenone; Ruthenium Compounds; Sarcoplasmic Reticulum; Sodium-Calcium Exchanger; Thapsigargin; Thiazepines | 2004 |
Kinetic analyses for species differences in P-glycoprotein-mediated drug transport.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Cyclosporine; Dexamethasone; Diltiazem; Dogs; Haplorhini; Humans; Kinetics; LLC-PK1 Cells; Mice; Rats; Species Specificity; Swine; Transfection | 2006 |
Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
Topics: Absorption; Adult; Area Under Curve; Cyclosporine; Diltiazem; Drug Administration Schedule; Drug Monitoring; Emulsions; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Postoperative Period; Vasodilator Agents | 2006 |
Co-administration of diltiazem and cyclosporine for kidney transplant recipients: a four year follow-up study.
Topics: Absorption; Adult; Area Under Curve; Blood Pressure; Creatinine; Cyclosporine; Diltiazem; Drug Administration Schedule; Drug Therapy, Combination; Emulsions; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Postoperative Period; Vasodilator Agents | 2006 |
Decision support tool to individualize cyclosporine dose in stable, long-term heart transplant recipients receiving metabolic inhibitors: overcoming limitations of cyclosporine C2 monitoring.
Topics: Area Under Curve; Bayes Theorem; Cardiovascular Agents; Cyclosporine; Decision Support Techniques; Diltiazem; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Feedback, Physiological; Heart Transplantation; Humans; Immunosuppressive Agents; Ketoconazole; Predictive Value of Tests; Time Factors | 2006 |
Comparative interaction of few antihypertensive drugs with cyclosporine-A in rats.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Aorta, Thoracic; Chromatography, High Pressure Liquid; Cyclosporine; Diltiazem; Drug Interactions; Enalapril; Losartan; Male; Olive Oil; Plant Oils; Propranolol; Rats; Rats, Wistar | 2007 |
[Prevention of diltiazem in tacrolimus-induced nephrotoxicity: experiment with rats].
Topics: Animals; Creatine; Cyclosporine; Diltiazem; Disease Models, Animal; Dose-Response Relationship, Drug; Kidney; Kidney Diseases; Kidney Transplantation; Male; Postoperative Period; Random Allocation; Rats; Rats, Sprague-Dawley; Tacrolimus | 2007 |
Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.
Topics: Adult; Aged; Asian People; Calcium Channel Blockers; Cyclosporine; Cytochrome P-450 CYP3A; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Polymorphism, Genetic; Time Factors; Young Adult | 2009 |
Modulation of human peripheral blood mononuclear cell proliferative response by diltiazem : in vitro comparison in younger versus older subjects.
Topics: Adult; Age Factors; Aged; Aging; Antibodies, Monoclonal; Antihypertensive Agents; CD3 Complex; Cell Proliferation; Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Interleukin-2; Leukocytes, Mononuclear; Male; Middle Aged; Pokeweed Mitogens; Tuberculin; Young Adult | 2009 |
Calcinosis cutis universalis with pediatric systemic lupus erythematosus.
Topics: Administration, Oral; Antiphospholipid Syndrome; Aspirin; Calcinosis; Child; Cyclosporine; Dermatologic Agents; Diltiazem; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Skin Ulcer; Treatment Outcome | 2010 |
Long-term follow-up of co-administration of diltiazem and cyclosporine in Chinese kidney transplant recipients.
Topics: Administration, Oral; Adult; Calcium Channel Blockers; Cyclosporine; Diltiazem; Drug Therapy, Combination; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Survival Rate | 2010 |
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome.
Topics: Adult; Back Muscles; Calcinosis; Comorbidity; Cyclosporine; Diltiazem; Drug Therapy, Combination; Female; Humans; Myositis; Prednisolone; Radionuclide Imaging; Skin Diseases; Technetium; Treatment Outcome | 2013 |
Diltiazem augments the influence of MDR1 genotype status on cyclosporine concentration in Chinese patients with renal transplantation.
Topics: Adolescent; Adult; Aged; Asian People; ATP Binding Cassette Transporter, Subfamily B; Calcineurin Inhibitors; Cyclosporine; Diltiazem; Drug Synergism; Drug Therapy, Combination; Female; Genotype; Humans; Kidney Transplantation; Male; Middle Aged; Polymorphism, Single Nucleotide; Young Adult | 2015 |
Diltiazem aggravates testicular function impairment induced by cyclosporine A or tacrolimus in unilateral nephrectomised rats.
Topics: Animals; Calcineurin Inhibitors; Calcium Channel Blockers; Cyclosporine; Diltiazem; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Gonadal Steroid Hormones; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Microscopy, Electron, Transmission; Nephrectomy; Rats; Rats, Sprague-Dawley; Semen Analysis; Sperm Motility; Tacrolimus; Testis | 2019 |
Takayasu arteritis in a rural hospital in Indonesia.
Topics: Adolescent; Angiography; Antihypertensive Agents; Cyclosporine; Diagnosis, Differential; Diltiazem; Drug Therapy, Combination; Electrocardiography; Female; Fever; Glucocorticoids; Hospitals, Rural; Humans; Immunosuppressive Agents; Indonesia; Methylprednisolone; Takayasu Arteritis | 2020 |
Impact of Electronic Health Record Interface Design on Unsafe Prescribing of Ciclosporin, Tacrolimus, and Diltiazem: Cohort Study in English National Health Service Primary Care.
Topics: Cohort Studies; Cyclosporine; Diltiazem; Electronic Health Records; England; Female; Humans; Inappropriate Prescribing; Male; Primary Health Care; Retrospective Studies; Tacrolimus | 2020 |
Diltiazem as a cyclosporine A-sparing agent in heart transplantation: Benefits beyond dose reduction.
Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Diltiazem; Drug Tapering; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Retrospective Studies | 2022 |